---
figid: PMC6721815__cancers-11-01176-g003
figtitle: Adaptive response-mediated resistance to BRAF inhibitors in melanoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC6721815
filename: cancers-11-01176-g003.jpg
figlink: /pmc/articles/PMC6721815/figure/cancers-11-01176-f003/
number: F3
caption: Adaptive response-mediated resistance to BRAF inhibitors in melanoma. (A)
  Negative feedback regulation of activated ERK on EGFR, RAF, and MEK, resulting in
  the downregulation of MAPK signalling.  highlights the relief of these downstream
  kinase-dependent negative feedback loops, following MAPK inhibition. (B) Transcriptionally-mediated
  feedback loops regulating resistance to BRAF inhibitors. These feedback loops result
  in re-activation of the MAPK pathway (DUSP, USP28, FOXD3/ERBB3. TGFB/EGFR), parallel
  activation of PI3K pathway (FOXD3/ERBB3, TGFB/EGFR), increase oxidative phosphorylation
  (PGC1α, lncRNA SAMMSON, MITF), and autophagy related genes mediated by TFEB. RAF,
  RAF proto oncogene; MEK/MAPK, mitogen-activated protein kinase; ERK, extracellular
  signal-related kinase. SHC, SHC adaptor protein 1; GRB2, growth factor receptor
  bound protein 2; SOS, son of sevenless; RAS, RAS proto-oncogene; USP28, Ubiquitin
  specific protease 28; KSR, Kinase Suppressor of RAS; EGFR, epidermal growth factor
  receptor; ERBB3, Erb-B2 receptor tyrosine kinase 3; PI3K, Phosphoinositide 3-kinase;
  AKT, AKT serine/threonine kinase; MITF, melanocyte inducing transcription factor;
  SOX10, SRY-box 10; TGFβ, transforming growth factor β, TFEB, transcription factor
  EB; FOXD3, forkhead box D3; DUSP, dual specificity phosphatase; PGC1α, Peroxisome
  proliferator-activated receptor-gamma coactivator (PGC)-1alpha, TF, transcription
  factors.
papertitle: Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma.
reftext: Azad Saei, et al. Cancers (Basel). 2019 Aug;11(8):1176.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9380214
figid_alias: PMC6721815__F3
figtype: Figure
redirect_from: /figures/PMC6721815__F3
ndex: d5931c5a-df05-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6721815__cancers-11-01176-g003.html
  '@type': Dataset
  description: Adaptive response-mediated resistance to BRAF inhibitors in melanoma.
    (A) Negative feedback regulation of activated ERK on EGFR, RAF, and MEK, resulting
    in the downregulation of MAPK signalling.  highlights the relief of these downstream
    kinase-dependent negative feedback loops, following MAPK inhibition. (B) Transcriptionally-mediated
    feedback loops regulating resistance to BRAF inhibitors. These feedback loops
    result in re-activation of the MAPK pathway (DUSP, USP28, FOXD3/ERBB3. TGFB/EGFR),
    parallel activation of PI3K pathway (FOXD3/ERBB3, TGFB/EGFR), increase oxidative
    phosphorylation (PGC1α, lncRNA SAMMSON, MITF), and autophagy related genes mediated
    by TFEB. RAF, RAF proto oncogene; MEK/MAPK, mitogen-activated protein kinase;
    ERK, extracellular signal-related kinase. SHC, SHC adaptor protein 1; GRB2, growth
    factor receptor bound protein 2; SOS, son of sevenless; RAS, RAS proto-oncogene;
    USP28, Ubiquitin specific protease 28; KSR, Kinase Suppressor of RAS; EGFR, epidermal
    growth factor receptor; ERBB3, Erb-B2 receptor tyrosine kinase 3; PI3K, Phosphoinositide
    3-kinase; AKT, AKT serine/threonine kinase; MITF, melanocyte inducing transcription
    factor; SOX10, SRY-box 10; TGFβ, transforming growth factor β, TFEB, transcription
    factor EB; FOXD3, forkhead box D3; DUSP, dual specificity phosphatase; PGC1α,
    Peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha, TF,
    transcription factors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - GRB2
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - XYLT2
  - SOS1
  - SOS2
  - BRAF
  - MAP2K1
  - MAP2K2
  - EPHB2
  - EGFR
  - ERBB3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - DUSP5
  - DUSP1
  - DUSP2
  - DUSP3
  - DUSP4
  - DUSP6
  - EIF2AK3
  - ZHX2
  - ARAF
  - RAF1
  - USP28
  - PPARGC1A
  - SAMMSON
  - MITF
  - SOX10
  - TFEB
  - TGFB1
  - TGFB2
  - TGFB3
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
